CatalystWireBeta

Result of AGM

In brief · summary, not quotable

PureTech Health plc announced that all resolutions proposed at its Annual General Meeting on June 10, 2026, were passed by shareholders. Key resolutions included the approval of the Annual Report and Accounts for the year ended December 31, 2025, with 99.97% of votes in favour, and the Directors' Remuneration Report, which received 95.84% approval. The re-election of directors also saw strong support, with Ms. Sharon Barber-Lui receiving 96.23% of votes for, Dr. Michele Holcomb 99.58%, Dr. John LaMattina 93.65%, Dr. Robert Langer 95.76%, Mr. Robert Lyne 99.64%, and Ms. Kiran Mazumdar-Shaw 82.04%. The reappointment of PricewaterhouseCoopers LLP as auditors was approved by 99.83% of votes.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes

The Annual General Meeting of PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company") was held at 11 a.m. EDT/4 p.m. BST on Wednesday, June 10, 2026.

All of the resolutions proposed at the Annual General Meeting were duly passed by the shareholders on a poll. The results of the poll, incorporating the proxy votes lodged in advance of the meeting, are set out below.

ResolutionsFor%Against%WithheldTotal votes cast
001. To approve the Company's Annual Report and Accounts for year ended 31 December 2025148,986,11499.9746,3920.0310,803149,032,506
002. To approve the Directors' Remuneration Report142,375,45995.846,172,7644.16495,086148,548,223
003. To re-elect Ms. Sharon Barber-Lui as a Director143,421,62296.235,617,3523.774,335149,038,974
004. To re-elect Dr. Michele Holcomb as a Director148,415,25799.58622,1640.425,888149,037,421
005. To re-elect Dr. John LaMattina as a Director139,575,20593.659,462,2106.355,894149,037,415
006. To re-elect Dr. Robert Langer as a Director142,363,97595.766,298,3094.24381,025148,662,284
007. To elect Mr. Robert Lyne as a Director148,496,57599.64539,3400.367,394149,035,915
008. To re-elect Ms. Kiran Mazumdar-Shaw as a Director122,266,59382.0426,769,32217.967,394149,035,915
009. To reappoint PricewaterhouseCoopers LLP as Auditors of the Company148,776,13399.83257,0010.1710,175149,033,134
010. To authorize the Audit Committee to determine the Auditors' remuneration148,750,72499.81286,7020.195,883149,037,426
011. To authorize the allotment of shares147,843,91399.61578,5440.39620,852148,422,457
012. To disapply pre-emption rights147,589,78199.39905,3230.61548,205148,495,104
013. To further disapply pre-emption rights for acquisitions and specified capital investments.146,398,00698.592,096,7901.41548,513148,494,796
014. To authorize market purchase of own shares148,852,41099.90155,2010.1035,698149,007,611
015. To authorize general meetings to be called on not less than 14 clear days' notice148,679,27899.76360,5010.243,530149,039,779

Notes:

  • As at June 10, 2026, the number of outstanding shares in the Company was 243,418,190 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.
  • The full text of the resolutions may be found in the Notice of the Annual General Meeting, copies of which are available on both the Company's website https://investors.puretechhealth.com/financials-filings/reports and on the National Storage Mechanism.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note